JP2012503489A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012503489A5 JP2012503489A5 JP2011529214A JP2011529214A JP2012503489A5 JP 2012503489 A5 JP2012503489 A5 JP 2012503489A5 JP 2011529214 A JP2011529214 A JP 2011529214A JP 2011529214 A JP2011529214 A JP 2011529214A JP 2012503489 A5 JP2012503489 A5 JP 2012503489A5
- Authority
- JP
- Japan
- Prior art keywords
- virus
- harvest
- micrometers
- respiratory syncytial
- buffer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241000700605 Viruses Species 0.000 claims 12
- 238000000034 method Methods 0.000 claims 9
- 238000003306 harvesting Methods 0.000 claims 7
- 241000725643 Respiratory syncytial virus Species 0.000 claims 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims 4
- 239000000872 buffer Substances 0.000 claims 4
- 238000005352 clarification Methods 0.000 claims 4
- 238000001914 filtration Methods 0.000 claims 4
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 claims 4
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims 3
- 229930006000 Sucrose Natural products 0.000 claims 3
- 239000011148 porous material Substances 0.000 claims 3
- 238000011084 recovery Methods 0.000 claims 3
- 239000005720 sucrose Substances 0.000 claims 3
- 238000009295 crossflow filtration Methods 0.000 claims 2
- 238000011026 diafiltration Methods 0.000 claims 2
- 229910000160 potassium phosphate Inorganic materials 0.000 claims 2
- 235000011009 potassium phosphates Nutrition 0.000 claims 2
- 239000011780 sodium chloride Substances 0.000 claims 2
- 102000004533 Endonucleases Human genes 0.000 claims 1
- 108010042407 Endonucleases Proteins 0.000 claims 1
- 101710163270 Nuclease Proteins 0.000 claims 1
- 229910019142 PO4 Inorganic materials 0.000 claims 1
- 239000007983 Tris buffer Substances 0.000 claims 1
- 239000012510 hollow fiber Substances 0.000 claims 1
- 230000002163 immunogen Effects 0.000 claims 1
- 238000004255 ion exchange chromatography Methods 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims 1
- 239000010452 phosphate Substances 0.000 claims 1
- 229920001184 polypeptide Polymers 0.000 claims 1
- 102000004196 processed proteins & peptides Human genes 0.000 claims 1
- 108090000765 processed proteins & peptides Proteins 0.000 claims 1
- 238000000746 purification Methods 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 230000006641 stabilisation Effects 0.000 claims 1
- 238000011105 stabilization Methods 0.000 claims 1
- 230000000087 stabilizing effect Effects 0.000 claims 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 claims 1
- 230000009385 viral infection Effects 0.000 claims 1
- 230000003612 virological effect Effects 0.000 claims 1
Applications Claiming Priority (11)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US9974908P | 2008-09-24 | 2008-09-24 | |
| US61/099,749 | 2008-09-24 | ||
| US10493308P | 2008-10-13 | 2008-10-13 | |
| US61/104,933 | 2008-10-13 | ||
| US12245608P | 2008-12-15 | 2008-12-15 | |
| US61/122,456 | 2008-12-15 | ||
| US18772109P | 2009-06-17 | 2009-06-17 | |
| US61/187,721 | 2009-06-17 | ||
| US22213109P | 2009-07-01 | 2009-07-01 | |
| US61/222,131 | 2009-07-01 | ||
| PCT/US2009/058174 WO2010036774A1 (en) | 2008-09-24 | 2009-09-24 | Methods for purification of viruses |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012503489A JP2012503489A (ja) | 2012-02-09 |
| JP2012503489A5 true JP2012503489A5 (enExample) | 2012-12-06 |
| JP5548207B2 JP5548207B2 (ja) | 2014-07-16 |
Family
ID=42060079
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011529214A Active JP5548207B2 (ja) | 2008-09-24 | 2009-09-24 | ウイルスの精製方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US8785173B2 (enExample) |
| EP (1) | EP2334328A4 (enExample) |
| JP (1) | JP5548207B2 (enExample) |
| KR (1) | KR20110074563A (enExample) |
| CN (1) | CN102215865B (enExample) |
| AU (1) | AU2009296628B2 (enExample) |
| BR (1) | BRPI0919250A2 (enExample) |
| CA (1) | CA2738024A1 (enExample) |
| WO (1) | WO2010036774A1 (enExample) |
Families Citing this family (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101189326B (zh) | 2004-12-23 | 2013-06-12 | 米迪缪尼有限公司 | 用于病毒增殖的非致瘤性mdck细胞系 |
| EP2069480B1 (en) | 2006-09-15 | 2014-03-19 | MedImmune, LLC | Mdck cell lines supporting viral growth to high titers and bioreactor process using the same |
| CN103952376A (zh) | 2008-09-24 | 2014-07-30 | 米迪缪尼有限公司 | 培养细胞、增殖和纯化病毒的方法 |
| JP5548207B2 (ja) | 2008-09-24 | 2014-07-16 | メディミューン，エルエルシー | ウイルスの精製方法 |
| AU2011262309B2 (en) * | 2010-06-01 | 2015-08-13 | Seqirus UK Limited | Concentration of influenza vaccine antigens without lyophilization |
| EP2598223B1 (en) | 2010-07-30 | 2022-04-06 | EMD Millipore Corporation | Chromatography media and method |
| WO2012048298A2 (en) | 2010-10-08 | 2012-04-12 | Caridianbct, Inc. | Methods and systems of growing and harvesting cells in a hollow fiber bioreactor system with control conditions |
| US9611458B2 (en) | 2010-12-27 | 2017-04-04 | Kyowa Hakko Kirin Co., Ltd | Method for preparing aqueous solution containing culture medium and chelating agent |
| CN102199198A (zh) * | 2011-03-28 | 2011-09-28 | 北京交通大学 | 人呼吸道合胞病毒f蛋白的纯化方法 |
| ES2653197T3 (es) * | 2011-07-20 | 2018-02-06 | Bgp Products B.V. | Procedimiento para producir antígeno ortomixoviral y vacunas |
| WO2015073918A1 (en) | 2013-11-16 | 2015-05-21 | Terumo Bct, Inc. | Expanding cells in a bioreactor |
| US11008547B2 (en) | 2014-03-25 | 2021-05-18 | Terumo Bct, Inc. | Passive replacement of media |
| MX383879B (es) * | 2014-05-13 | 2025-03-14 | Amgen Inc | Sistema y métodos de control del proceso para usar con filtros y procesos de filtración. |
| SG11201700030UA (en) | 2014-09-02 | 2017-02-27 | Emd Millipore Corp | High surface area fiber media with nano-fibrillated surface features |
| WO2016049421A1 (en) | 2014-09-26 | 2016-03-31 | Terumo Bct, Inc. | Scheduled feed |
| US20170298091A1 (en) | 2014-12-08 | 2017-10-19 | Emd Millipore Corporation | Mixed Bed Ion Exchange Adsorber |
| WO2017004592A1 (en) | 2015-07-02 | 2017-01-05 | Terumo Bct, Inc. | Cell growth with mechanical stimuli |
| EP3353193A4 (en) * | 2015-09-22 | 2019-04-03 | Sanofi Pasteur Biologics, LLC | CLEANING OF THE RESPIRATORY SYNZYTIAL VIRUS |
| CN106337045A (zh) * | 2016-05-24 | 2017-01-18 | 微基生物科技（上海）有限公司 | 一种防止pcr污染的方法及其应用 |
| US11965175B2 (en) | 2016-05-25 | 2024-04-23 | Terumo Bct, Inc. | Cell expansion |
| US11104874B2 (en) | 2016-06-07 | 2021-08-31 | Terumo Bct, Inc. | Coating a bioreactor |
| US11685883B2 (en) | 2016-06-07 | 2023-06-27 | Terumo Bct, Inc. | Methods and systems for coating a cell growth surface |
| EP3601543A4 (en) * | 2017-03-30 | 2021-01-27 | Merck Sharp & Dohme Corp. | ADDING NUCLEASES DIRECTLY TO CELL CULTURE TO FACILITATE DIGESTION AND RELEASE OF HOST CELL NUCLEIC ACIDS |
| US12234441B2 (en) | 2017-03-31 | 2025-02-25 | Terumo Bct, Inc. | Cell expansion |
| US11624046B2 (en) | 2017-03-31 | 2023-04-11 | Terumo Bct, Inc. | Cell expansion |
| US11629332B2 (en) | 2017-03-31 | 2023-04-18 | Terumo Bct, Inc. | Cell expansion |
| GEP20237575B (en) * | 2017-10-16 | 2023-12-25 | Serum Institute Of India Pvt Ltd | Stable vaccine compositions comprising inter alia live attenuated recombinant dengue virus and process for preparation thereof |
| WO2019092084A1 (en) * | 2017-11-08 | 2019-05-16 | Blue Sky Vaccines Gmbh | So3 chromatography for use in a method for virus purification |
| CN111447947B (zh) | 2017-12-07 | 2024-01-12 | 默沙东有限责任公司 | 登革病毒疫苗组合物的制剂 |
| US10988726B2 (en) | 2018-08-19 | 2021-04-27 | Cytera Cellworks Limited | Systems and methods for automated cell culturing |
| DE102018215551A1 (de) | 2018-09-12 | 2020-03-12 | Virolutions Biotech Gmbh | Verfahren zur Herstellung eines antitumoralen Arenavirus sowie Arenavirusmutanten |
| CN113330111A (zh) * | 2018-11-21 | 2021-08-31 | 西方溶瘤细胞有限公司 | 病毒的制造 |
| CN111763661B (zh) * | 2019-04-02 | 2022-07-29 | 普莱柯生物工程股份有限公司 | 一种病毒纯化的方法、制备的疫苗组合物及其应用 |
| JP7712284B2 (ja) * | 2020-03-12 | 2025-07-23 | バヴァリアン・ノルディック・アクティーゼルスカブ | ポックスウイルスの安定性を改善する組成物 |
| CN115698305A (zh) * | 2020-06-11 | 2023-02-03 | 2赛文缇生物公司 | 用于制造病毒载体的方法 |
| JP2023530445A (ja) * | 2020-06-17 | 2023-07-18 | メイッサ ヴァクシーン，インコーポレイテッド | キメラｒｓｖおよびコロナウイルスタンパク質、免疫原性組成物、ならびに使用方法 |
| GB2619893A (en) | 2021-03-23 | 2023-12-20 | Terumo Bct Inc | Cell capture and expansion |
| JP7716233B2 (ja) * | 2021-05-28 | 2025-07-31 | ダイセン・メンブレン・システムズ株式会社 | 微小有用物質の分離精製方法と分離精製装置 |
| CN113930353B (zh) * | 2021-08-31 | 2023-07-07 | 广西大学 | 一种耐亚硒酸盐的粘质沙雷氏菌及其还原特性鉴定方法 |
| JP7764758B2 (ja) | 2021-12-27 | 2025-11-06 | 株式会社島津製作所 | 濃縮装置、それを備えた分析システムおよび濃縮方法 |
| US12209689B2 (en) | 2022-02-28 | 2025-01-28 | Terumo Kabushiki Kaisha | Multiple-tube pinch valve assembly |
| USD1099116S1 (en) | 2022-09-01 | 2025-10-21 | Terumo Bct, Inc. | Display screen or portion thereof with a graphical user interface for displaying cell culture process steps and measurements of an associated bioreactor device |
| CN115505571B (zh) * | 2022-11-24 | 2023-03-10 | 上海倍谙基生物科技有限公司 | 适用于悬浮培养lmh细胞生产禽腺病毒的无血清添加剂 |
Family Cites Families (48)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NO162160C (no) | 1987-01-09 | 1989-11-15 | Medi Cult As | Serumfritt vekstmedium, samt anvendelse derav. |
| US5118513A (en) | 1987-07-02 | 1992-06-02 | The Procter & Gamble Company | Method for enhancing bioavailability of iron-calcium mineral supplements |
| US5854037A (en) | 1989-08-28 | 1998-12-29 | The Mount Sinai School Of Medicine Of The City University Of New York | Recombinant negative strand RNA virus expression systems and vaccines |
| US5166057A (en) | 1989-08-28 | 1992-11-24 | The Mount Sinai School Of Medicine Of The City University Of New York | Recombinant negative strand rna virus expression-systems |
| US20060019350A1 (en) | 1989-08-28 | 2006-01-26 | Peter Palese | Recombinant negative strand RNA virus expression system and vacccines |
| US5786199A (en) | 1989-08-28 | 1998-07-28 | The Mount Sinai School Of Medicine Of The City University Of New York | Recombinant negative strand RNA virus expression systems and vaccines |
| US5840520A (en) | 1989-08-28 | 1998-11-24 | Aviron | Recombinant negative strand RNA virus expression systems |
| US6001634A (en) | 1989-08-28 | 1999-12-14 | Palese; Peter | Recombinant negative strand RNA viruses |
| US6887699B1 (en) | 1990-05-22 | 2005-05-03 | Medimmune Vaccines, Inc. | Recombinant negative strand RNA virus expression systems and vaccines |
| US6245549B1 (en) * | 1990-06-28 | 2001-06-12 | Connaught Laboratories Limited | Production of virus and purification of viral envelope proteins for vaccine use |
| GB9215834D0 (en) | 1992-07-24 | 1992-09-09 | Celltech Ltd | Cell culture |
| US5824536A (en) | 1994-08-23 | 1998-10-20 | St. Jude Children's Research Hospital | Influenza virus replicated in mammalian cell culture and vaccine production |
| US7465574B2 (en) | 1994-09-30 | 2008-12-16 | Medimmune, Llc | Recombinant RSV virus expression systems and vaccines |
| DE19612966B4 (de) | 1996-04-01 | 2009-12-10 | Novartis Vaccines And Diagnostics Gmbh & Co. Kg | MDCK-Zellen und Verfahren zur Vermehrung von Influenzaviren |
| AU732703B2 (en) | 1996-11-20 | 2001-04-26 | Crucell Holland B.V. | An improved method for the production and purification of adenoviral vectors |
| US6544785B1 (en) | 1998-09-14 | 2003-04-08 | Mount Sinai School Of Medicine Of New York University | Helper-free rescue of recombinant negative strand RNA viruses |
| US8715940B2 (en) | 1999-04-06 | 2014-05-06 | Wisconsin Alumni Research Foundation | Method of making recombinant influenza virus |
| EP1210410B1 (en) | 1999-08-27 | 2008-01-16 | Invitrogen Corporation | Metal binding compounds and their use in cell culture medium compositions |
| US6544424B1 (en) | 1999-12-03 | 2003-04-08 | Refined Technology Company | Fluid filtration system |
| DE60137345D1 (de) | 2000-04-28 | 2009-02-26 | St Jude Childrens Res Hospital | Dna-transfektionssystem zur erzeugung von infektiösen negativsträngigen rna virus |
| WO2002002752A1 (en) | 2000-06-23 | 2002-01-10 | Akzo Nobel N.V. | Attenuated bovine respiratory syncytial virus |
| DE10144906B4 (de) | 2001-09-12 | 2013-11-28 | Novartis Vaccines And Diagnostics Gmbh | Verfahren zur großtechnischen Herstellung von Impfstoffen |
| DE10144903A1 (de) | 2001-09-12 | 2003-03-27 | Chiron Behring Gmbh & Co | Vermehrung von Viren in Zellkultur |
| US6951752B2 (en) | 2001-12-10 | 2005-10-04 | Bexter Healthcare S.A. | Method for large scale production of virus antigen |
| CA2477037C (en) | 2002-02-21 | 2014-12-09 | Mount Sinai School Of Medicine | Recombinant negative strand virus rna expression systems and vaccines |
| WO2003086443A1 (en) | 2002-04-11 | 2003-10-23 | Medimmune Vaccines, Inc. | Spray freeze dry of compositions for intranasal administration |
| US20050158342A1 (en) | 2003-12-23 | 2005-07-21 | Medimmune, Inc. | Multi plasmid system for the production of influenza virus |
| US7465456B2 (en) | 2002-04-26 | 2008-12-16 | Medimmune, Llc | Multi plasmid system for the production of influenza virus |
| CN103540613A (zh) | 2002-04-26 | 2014-01-29 | 米迪缪尼有限公司 | 制备流感病毒的多质粒系统 |
| ATE427990T1 (de) | 2002-04-30 | 2009-04-15 | Oncolytics Biotech Inc | Verbesserte reinigungsmethode fur viren |
| US6825306B2 (en) | 2002-08-16 | 2004-11-30 | The Goodyear Tire & Rubber Company | Functionalized monomers for synthesis of rubbery polymers |
| JP2004135665A (ja) | 2002-09-25 | 2004-05-13 | Nihon Pharmaceutical Co Ltd | ウイルスの分離法 |
| US20060002862A1 (en) * | 2002-12-17 | 2006-01-05 | Medimmune Vaccines, Inc. | High pressure spray-dry of bioactive materials |
| EP1597400B8 (en) | 2003-02-25 | 2013-10-09 | MedImmune, LLC | Methods of producing influenza vaccine compositions |
| US7687240B2 (en) * | 2003-03-18 | 2010-03-30 | Wyeth Holdings Corporation | Process for increasing RSV surface glycoprotein yields using a mutant strain of RSV |
| JP2007525178A (ja) | 2003-04-25 | 2007-09-06 | メッドイミューン バクシーンズ，インコーポレイティド | メタニューモウイルス株、そのワクチン製剤における用途、抗原性配列の発現のためのベクターとしての用途、並びにウイルス増殖方法 |
| JP2006525815A (ja) | 2003-05-28 | 2006-11-16 | ウィスコンシン・アラムナイ・リサーチ・ファウンデイション | Ｐｏｌｉｉプロモーターおよびリボザイムを有する組換えインフルエンザベクター |
| ES2329607T3 (es) | 2004-02-23 | 2009-11-27 | Crucell Holland B.V. | Metodos de purificacion de virus. |
| NZ551640A (en) | 2004-05-20 | 2010-05-28 | Id Biomedical Corp | Process for the production of an influenza vaccine |
| KR101346989B1 (ko) | 2004-10-06 | 2014-02-06 | 메디뮨 엘엘씨 | 냉장 온도 안정성 인플루엔자 백신 조성물 |
| CN101189326B (zh) * | 2004-12-23 | 2013-06-12 | 米迪缪尼有限公司 | 用于病毒增殖的非致瘤性mdck细胞系 |
| US7790434B2 (en) | 2005-06-21 | 2010-09-07 | Medimmune, Llc | Methods and compositions for expressing negative-sense viral RNA in canine cells |
| CA2613284A1 (en) | 2005-06-21 | 2007-01-04 | Medimmune Vaccines, Inc. | Methods and compositions for expressing negative-sense viral rna in canine cells |
| AU2007240448B8 (en) | 2006-04-19 | 2014-03-06 | Medimmune Llc. | Methods and compositions for expressing negative-sense viral RNA in canine cells |
| US7875446B2 (en) | 2006-04-20 | 2011-01-25 | Wyeth Llc | Purification processes for isolating purified vesicular stomatitis virus from cell culture |
| EP2069480B1 (en) | 2006-09-15 | 2014-03-19 | MedImmune, LLC | Mdck cell lines supporting viral growth to high titers and bioreactor process using the same |
| JP5548207B2 (ja) | 2008-09-24 | 2014-07-16 | メディミューン，エルエルシー | ウイルスの精製方法 |
| CN103952376A (zh) | 2008-09-24 | 2014-07-30 | 米迪缪尼有限公司 | 培养细胞、增殖和纯化病毒的方法 |
-
2009
- 2009-09-24 JP JP2011529214A patent/JP5548207B2/ja active Active
- 2009-09-24 AU AU2009296628A patent/AU2009296628B2/en not_active Ceased
- 2009-09-24 CN CN2009801468459A patent/CN102215865B/zh not_active Expired - Fee Related
- 2009-09-24 WO PCT/US2009/058174 patent/WO2010036774A1/en not_active Ceased
- 2009-09-24 BR BRPI0919250A patent/BRPI0919250A2/pt not_active IP Right Cessation
- 2009-09-24 CA CA2738024A patent/CA2738024A1/en not_active Abandoned
- 2009-09-24 KR KR1020117009305A patent/KR20110074563A/ko not_active Abandoned
- 2009-09-24 US US13/120,638 patent/US8785173B2/en active Active
- 2009-09-24 EP EP09816835A patent/EP2334328A4/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012503489A5 (enExample) | ||
| CA2584142A1 (en) | Improved viral purification methods | |
| JP5129805B2 (ja) | 細胞培養物から精製水疱性口内炎ウイルスを単離するための精製プロセス | |
| RU2015103990A (ru) | Способы культивирования клеток, размножения и очистки вирусов | |
| CA2482512A1 (en) | Improved viral purification methods | |
| US11629339B2 (en) | Aseptic purification process for viruses | |
| ES2753300T3 (es) | Procedimiento de purificación de virus o vectores virales envueltos | |
| JP2011524887A5 (enExample) | ||
| JP2008512473A5 (enExample) | ||
| JP2009034115A5 (enExample) | ||
| JP2015521628A5 (enExample) | ||
| RU2015155822A (ru) | Получение белковых продуктов из бобовых с пониженной терпкостью | |
| ES2733489T3 (es) | Proceso de purificación de poliovirus a partir de cultivos celulares | |
| JP2016104000A5 (enExample) | ||
| HK1248763A1 (en) | Aseptic purification process for viruses | |
| MX386767B (es) | Filtración de virus de medio de cultivo celular. | |
| JP2016528233A5 (enExample) | ||
| CN109134622B (zh) | 口蹄疫病毒抗原的多步连续集成纯化方法 | |
| RU2015155602A (ru) | Способ получения аполипопротеина a-i (аро a-i) | |
| JP2016534748A (ja) | 処理済みフィルタ | |
| RU2493872C1 (ru) | Способ очистки вируса гриппа | |
| RU2021126015A (ru) | ОЧИСТКА иРНК ФИЛЬТРАЦИЕЙ В ТАНГЕНЦИАЛЬНОМ ПОТОКЕ | |
| RU97729U1 (ru) | Устройство для получения вирионов хантавирусов из вируссодержащей суспензии | |
| JP6467139B2 (ja) | 狂犬病ウイルスの複製促進・増強方法 | |
| RU2009149040A (ru) | Способ получения комбинированной бивалентной, культуральной, инактивированной, концентрированной, очищенной вакцины для профилактики геморрагической лихорадки с почечным синдромом |